Paper Review Records
All Paper Review Records
30 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
62
days
An In Silico–In Vitro Framework for Model‐Informed Precision Dosing in Oncology: Proof‐of‐Principle for Doxorubicin in Patient‐Derived Sarcoma Spheroids
Authors
Hannah K. Dorn; Micaela Freitas; Severin Manser; Marko Weidmann; Ina Oehme; Heike Peterziel; Olaf Witt; Jens M. Kelm; Lars KuepferShow moreShow less
Affiliations
1. Institute for Systems Medicine With Focus on Organ Interaction University Hospital RWTH Aachen University Aachen Germany; 2. PreComb Therapeutics AG Hombrechtikon Switzerland; 3. Hopp Children's Cancer Center Heidelberg (KiTZ) Heidelberg Germany; 4. Clinical Cooperation Unit Pediatric Oncology (B310) German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) Heidelberg Germany; 5. National Center for Tumor Diseases Heidelberg Heidelberg Germany; 6. Department of Pediatric Oncology, Hematology, Immunology and Pulmonology Heidelberg University Hospital Heidelberg GermanyShow moreShow less
88
days
Nine‐Year Trends in Treatment Patterns, Comorbidities, and Healthcare Utilization in Type 2 Diabetes in France: Insights From Integrated Health Data
Authors
Romane Le Goff; Amandine Gouverneur; Cédric Collin; Pascaline Rabiega; Mathieu MolimardShow moreShow less
Affiliations
1. Real World Solutions IQVIA Paris France; 2. Department of Medical Pharmacology Bordeaux University Bordeaux FranceShow moreShow less
141
days
The Relationship Between Pre‐Operative Ipilimumab and Nivolumab Pharmacokinetics and Treatment Outcome in Locoregionally Advanced Urothelial Cancer
Authors
Sybrand W. J. Zielhuis; Karen A. M. de Jong; Hinke Huisman‐Siebinga; Lisa T. van der Heijden; Bart A. W. Jacobs; Jos H. Beijnen; Hilde Rosing; Chantal F. Stockem; Jeroen van Dorp; Michiel S. van der Heijden; Alwin D. R. HuitemaShow moreShow less
Affiliations
1. Department of Pharmacy & Pharmacology The Netherlands Cancer Institute Amsterdam the Netherlands; 2. Department of Medical Oncology The Netherlands Cancer Institute Amsterdam the Netherlands; 3. Department of Molecular Carcinogenesis The Netherlands Cancer Institute Amsterdam the Netherlands; 4. Department of Clinical Pharmacy University Medical Center Utrecht, Utrecht University Utrecht the Netherlands; 5. Princess Máxima Center for Pediatric Oncology Utrecht the NetherlandsShow moreShow less
104
days
Application of Mechanistic Modeling to Support Dose‐Relevant Decision Making for CAR ‐T Cell Therapy in Oncology: A Systematic Scoping Review
Authors
Dolapo Odujinrin; Graham McClellandShow moreShow less
Affiliations
1. Centre for Pharmaceutical Medicine Research, School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London London UKShow moreShow less
76
days
Healthy Participant Versus Patient Selection for Clinical Pharmacology Studies in Small‐Molecule Oncology Drug Development
Authors
Paridhi Gupta; Zheyi Hu; Li Zhu; Lora HamuroShow moreShow less
Affiliations
1. Clinical Pharmacology Bristol Myers Squibb Princeton New Jersey USAShow moreShow less
132
days
Landscape Analysis of Digital Health Technology Use for Remote Data Acquisition in CDER ‐Regulated Submissions, 2023–2025
Authors
Ayoub Suliman; Norah Xiao; Leonard Sacks; Elizabeth Kunkoski; Ryan Robinson; Dianne Paraoan; Hussein Ezzeldin; Anindita Saha; Qi Liu; Hao Zhu; Yutao Gong; Hanrui Zhang; Ruihao Huang; Jeffrey Siegel; Jonas Santiago; Elizabeth HartShow moreShow less
Affiliations
1. Office of Medical Policy, Center for Drug Evaluation and Research U.S. Food and Drug Administration Silver Spring Maryland USA; 2. Office of Translational Sciences, Center for Drug Evaluation and Research U.S. Food and Drug Administration Silver Spring Maryland USA; 3. Office of Drug Evaluation Sciences, Office of New Drugs, Center for Drug Evaluation and Research U.S. Food and Drug Administration Silver Spring Maryland USAShow moreShow less
FAQ
How long does CTS-Clinical and Translational Science take to review a manuscript?
As of 2026-11-17, CrushSCI has 30 complete review records for CTS-Clinical and Translational Science. The fastest paper went from submission to acceptance in 31 days (Posaconazole Target Attainment in Critically Ill Children: A 15‐Year Single‐Center Retrospective Analysis, received 2026-07-24, accepted 2026-08-24); the slowest took 255 days. The average is 126.0 days and the median is 123 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
